Suspected low-grade glioma: is deferring treatment safe? - Wikidata - awgldk - TriplyDB

Suspected low-grade glioma: is deferring treatment safe?

Suspected low-grade glioma: is deferring treatment safe?

http://www.wikidata.org/entity/Q44551360

about

Magnetic resonance perfusion for differentiating low grade from high grade gliomas at first presentation Biopsy versus resection for the management of low-grade gliomas Biopsy versus resection for the management of low-grade gliomas Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: a review.Neuroimaging in glioma therapy.Maximizing safe resection of low- and high-grade glioma.3'-Deoxy-3'-[(18)F]fluorothymidine and O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in Patients with Suspicious Recurrence of Glioma after Multimodal Treatment: Initial Results of a Retrospective Comparative Study Does early resection of presumed low-grade glioma improve survival? A clinical perspective.Postoperative radiotherapy of astrocytomas.Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas.Biopsy versus resection for the management of low-grade gliomas.Controversies in the therapy of low-grade glioma: when and how to treat.Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis Adult low-grade glioma: 19-year experience at a single institution.Update on the therapeutic approaches to brain tumors.Surgery for low-grade gliomas: current evidence and controversies.Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery.Oligodendroglial tumors.Proliferation and aneusomy predict survival of young patients with astrocytoma grade II.Effect of age on treatment decisions in low-grade glioma.Low-grade gliomas: management issues.Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic.Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.Applications of neural and mesenchymal stem cells in the treatment of gliomas.Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities Assessment of nuclear size, nuclear DNA content and proliferation index in stereotaxic biopsies from brain tumours.Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery.Radial expansion rates and tumor growth kinetics predict malignant transformation in contrast-enhancing low-grade diffuse astrocytoma.Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors.Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy.Role of surgical resection in low- and high-grade gliomas.Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival.Management of primary brain tumors--1996.Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.The preoperative use of navigated transcranial magnetic stimulation facilitates early resection of suspected low-grade gliomas in the motor cortex.Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors.Glial microtumor with 17-year of postoperative follow up.Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors.

P2860

Q24187505-C7BBFFBD-7A16-4FD1-976F-D2326F9400C6 Q24197750-164A3648-A9A9-4BBE-843F-99136A35FACA Q24234687-70FB51E9-5F9C-4365-AE51-F08EEE5256A0 Q30680698-47953284-7B74-4543-8E79-D176BC0A7675 Q30988178-6D10B751-9449-4D74-B7C7-1103507081C1 Q31095748-90430C82-7E21-48EF-9DC6-4CEBA86705FA Q33704202-3C3A7ADF-DD90-4FFB-8576-419EF91D3D78 Q33867304-98FA2F86-21C7-4769-AA53-B83C4A466CE5 Q34210447-1FCAACAA-5EEF-4D71-8567-7D87D115BBEA Q34390352-D4608754-68A7-4313-B6AA-BF3354C0B245 Q34555925-AC1FBD6F-FD4D-476A-981E-A2A18D93A98B Q34969223-9AD276BA-9E69-4248-9870-A5B9C198FB41 Q35038477-D2B70931-EDE0-4587-960D-5EE2837A3DCD Q35183129-EDB28876-EC7F-4211-B7CF-D551CF614CF1 Q35576174-0ACB86A5-7AED-4911-A928-48527717CD27 Q36307787-D4BF31F7-1857-4F87-A522-95EFD62FA1EC Q36318219-BFBAFC28-AADE-40F7-B2F5-137E405B6D95 Q36453277-83446175-7AF7-44D9-8BAF-5BFC978413D4 Q36670841-F60D449C-73F9-4D0B-BD93-003E3ED7226A Q36758794-5AF04DA7-F4D9-4ED0-873C-EC2E74C52374 Q37030794-DCEA14BF-0620-41CA-AE02-066087803807 Q37344962-065D8E02-4473-4F5F-8190-25290A6028BD Q37462007-9A7F329D-EA13-4379-823E-43FB01050CB3 Q37483966-6F5FDDB1-7283-4317-90EE-D6E57195BCCD Q38055317-7478341D-951C-4109-A239-26E08BB17C66 Q39398417-4D5AE8EC-865D-4AE3-836C-BE3B5A5A9705 Q41354879-5792F26F-9886-4841-BD7F-01E1307C7D72 Q41850051-8F717F51-06D0-4E15-B763-B17C08EA3D34 Q42011021-593B68BD-F68E-4ED6-92FC-7C37820D9F70 Q44453455-7B47CDC7-0DAE-44D5-BC51-6F4289D8AD7C Q46723190-42832645-456E-45D8-BC22-A147EB49C55A Q48119215-36AE3CEE-577B-4C96-8448-A2276526C65B Q48455096-96E8C999-9F59-44D7-933A-48A34B3D1E67 Q48520992-55BFA187-FC57-468A-A509-2DB9AEE6A17E Q49087518-D120F7AD-59BB-494B-80E3-FF824654186E Q50907799-A93A7FA6-E120-4A30-988E-CE53C51B78EC Q50977755-EC0FECE1-2349-4518-AA11-004578E75881 Q55463486-C345AE7C-13D6-42F2-8520-A0400993B449 Q55470597-A7D078B0-1BB1-4AC4-B2FD-E42DEC7D7D97

P2860

Suspected low-grade glioma: is deferring treatment safe?

http://www.wikidata.org/entity/Q44551360

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年学术文章

@wuu

1992年学术文章

@zh

1992年学术文章

@zh-cn

1992年学术文章

@zh-hans

1992年学术文章

@zh-my

1992年学术文章

@zh-sg

1992年學術文章

@yue

1992年學術文章

@zh-hant

name

Suspected low-grade glioma: is deferring treatment safe?

@en

Suspected low-grade glioma: is deferring treatment safe?

@nl

type

label

Suspected low-grade glioma: is deferring treatment safe?

@en

Suspected low-grade glioma: is deferring treatment safe?

@nl

prefLabel

Suspected low-grade glioma: is deferring treatment safe?

@en

Suspected low-grade glioma: is deferring treatment safe?

@nl

P1433

Q44551360-36F79AFF-D407-483F-B5DA-DFC3C2A45602

P1476

Q44551360-183AB35A-40DD-4F8F-B71A-DA01138409BA

P2093

Q44551360-0E927F82-7BFB-4E37-ACA9-6370F8EC94C3

Q44551360-98669AC6-58CE-4498-B604-DA2A31E0AE32

Q44551360-F8E3D564-2BAA-4ACB-9BFF-626D19CBBDD6

P2860

Q44551360-0B858414-5995-412B-9196-39261F9E2751

Q44551360-24865F54-7D47-4DD0-92FE-A5558A949819

Q44551360-4791AB4C-135D-47DD-BDE5-0B968A241A09

Q44551360-A0F5CCF5-92BC-4008-9699-674E124E945B

Q44551360-A7E032DC-86A9-41C6-B715-0A40B7AB7931

Q44551360-B593BDFF-AC8B-4F46-B9E8-3FB32290E463

Q44551360-BDD9B305-D2BF-4FDF-BB37-FBB0C77A3A9C

Q44551360-DE1DB9CC-EEFB-45F7-89B7-6B068A4F5F77

Q44551360-ECC5E170-BFC1-42FF-8388-9A64ACB916C7

P304

Q44551360-19D8F75D-2706-4D5D-8E6B-4B20A8DAE150

P31

Q44551360-145A8C5E-8B0C-4E97-8BEB-F760CE3276C4

P356

Q44551360-A8073E2A-4A5A-4CCC-8EA3-DA251841A82B

P433

Q44551360-92AC9289-0978-40D3-A9E9-B89FBEE8C63A

P478

Q44551360-F91DF193-C4CA-4D25-A72D-1686E873991E

P577

Q44551360-952001BA-D13C-4A06-BE41-5B07F9B40D91

P698

Q44551360-D8AD8587-DFBA-41A4-9477-FBC7C5EA777E

P356

P1433

Annals of Neurology

P1476

Suspected low-grade glioma: is deferring treatment safe?

@en

P2093

Lew R

http://www.w3.org/2001/XMLSchema#string

Recht LD

http://www.w3.org/2001/XMLSchema#string

Smith TW

http://www.w3.org/2001/XMLSchema#string

P2860

Stereotactic resection of intra-axial cerebral lesions in partial epilepsy.

Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas.

Low-grade astrocytomas: treatment results and prognostic variables.

Treatment of grades I and II brain astrocytomas. The role of radiotherapy.

Magnetic resonance imaging in partial complex epilepsy.

CNS tumor induction by radiotherapy: a report of four new cases and estimate of dose required.

Neuropsychologic impairment in astrocytoma survivors.

Intracerebral masses in patients with intractable partial epilepsy.

Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume.

P304

431-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.410310413

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

1992-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1586143

http://www.w3.org/2001/XMLSchema#string